Abstract Details

Title Chemotherapy Exposure Disrupts the Gliogenic Microenvironment

Topic Child Neurology and Developmental Neurology

Presentation(s) P3 - (-)

Poster/Presentation
Number 332

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Michelle Monje, MD, PhD, FAAN (Stanford University)	An immediate family member of Dr. Monje has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for MapLight Therapeutics . An immediate family member of Dr. Monje has stock in MapLight Therapeutics .

��ɫ����